Bruce A. Goldsmith - 27 May 2022 Form 4 Insider Report for Passage BIO, Inc. (PASG)

Role
CEO and President, Director
Signature
/s/ Edgar Cale, Attorney-in-Fact
Issuer symbol
PASG
Transactions as of
27 May 2022
Net transactions value
$0
Form type
4
Filing time
01 Jun 2022, 16:25:24 UTC
Previous filing
23 Mar 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PASG Stock Option (Right to Buy) Award $0 +100,000 $0.000000 100,000 27 May 2022 Common Stock 100,000 $1.86 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The stock option vests in full on September 1, 2022, subject to the reporting person's continuous service to the issuer on such date.